Creo Medical Group Plc (CREO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | -1,000 | -2,800 | -4,041 | -5,744 | -3,146 |
| Accounts receivable | -1,000 | -1,400 | -1,570 | -3,170 | -394 |
| Other Working Capital | -100 | -5,500 | -2,820 | -4,262 | 2,059 |
| Other Operating Activity | -20,100 | -11,900 | -16,623 | -12,835 | -14,798 |
| Operating Cash Flow | $-22,200 | $-21,600 | $-25,054 | $-26,011 | $-16,279 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -300 | -1,200 | -3,179 | -5,976 | -485 |
| Net Acquisitions | 0 | -2,400 | -2,753 | -1,752 | -20,586 |
| Purchase Sale Intangibles | -100 | -400 | -95 | -146 | -91 |
| Other Investing Activity | 15,700 | -14,300 | 66 | 31 | 195 |
| Investing Cash Flow | $15,300 | $-18,300 | $-5,961 | $-7,843 | $-20,968 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,400 | 200 | 2,851 | 144 | 2,055 |
| Debt Repayment | -600 | -1,400 | -1,572 | -1,844 | -497 |
| Common Stock Issued | 11,100 | 31,700 | 70 | 34,208 | 159 |
| Other Financing Activity | -700 | -700 | -827 | -515 | -391 |
| Financing Cash Flow | $16,200 | $29,800 | $522 | $31,993 | $1,326 |
| Exchange Rate Effect | N/A | 0 | 56 | 303 | -36 |
| Beginning Cash Position | 3,000 | 13,100 | 43,534 | 45,092 | 81,048 |
| End Cash Position | 12,300 | 3,000 | 13,097 | 43,534 | 45,092 |
| Net Cash Flow | $9,300 | $-10,100 | $-30,493 | $-1,861 | $-35,921 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,200 | -21,600 | -25,054 | -26,011 | -16,279 |
| Capital Expenditure | -400 | -1,600 | -3,274 | -6,122 | -576 |
| Free Cash Flow | -22,600 | -23,200 | -28,328 | -32,133 | -16,855 |